Our second mentoring lunch for Spring 2023 is with Dr Jolanta Grembecka, University of Michigan. These lunches are excellent opportunities for students to network with visiting faculty and learn about cancer research being done at other institutions, in an informal setting. More info on Dr. Grembecka’s research can be found here (https://www.pathology.med.umich.edu/grembecka-cierpicki-lab) and below.
The focus of the Grembecka/Cierpicki laboratories is discovery and development of small molecules for targeted therapies in cancer. Targeted cancer therapies use drugs that selectively inhibit growth of cancer cells by blocking proteins directly involved in cancer cell division and spread. By focusing on inhibiting proteins directly involved in molecular and cellular changes that are specific to cancer, targeted cancer therapies are more effective and much less harmful to normal cells than other types of treatment, such as chemotherapy or radiotherapy.
FRIENDLY REMINDER
All onsite visitors are required to have the COVID vaccination and booster at Dana-Farber and are required to wear a hospital-issued mask when in public facing areas. Masks are available upon entry into the building. Prior to your arrival on-site, you will need to attest symptoms here: https://prescreen.massgeneralbrigham.org. Select visitor/essential visitor and answer the questions.
LOCATION: STATUS:CONFIRMED DTSTART:20230228T170000Z DTEND:20230228T180000Z END:VEVENT END:VCALENDAR